Medicare Program; CY 2025 Part A Premiums for the Uninsured Aged and for Certain Disabled Individuals Who Have Exhausted Other Entitlement, 90015-90018 [2024-26473]
Download as PDF
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
with the statute, for CY 2025. We also
note that, even if notice and comment
procedures were required for this
notice, we would find good cause, for
the previously stated reason, to waive
the delay in effective date of the notice,
as additional delay would be contrary to
the public interest under section
1871(e)(1)(B)(ii) of the Act. Publication
of this notice is consistent with section
1839 of the Act, and we believe that any
potential delay in the effective date of
the notice, if such delay were required
at all, could cause unnecessary
confusion for both the agency and
Medicare beneficiaries.
Chiquita Brooks-LaSure,
Administrator of the Centers for
Medicare & Medicaid Services,
approved this document on October 31,
2024.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
[FR Doc. 2024–26474 Filed 11–8–24; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–8087–N]
RIN 0938–AV37
Medicare Program; CY 2025 Part A
Premiums for the Uninsured Aged and
for Certain Disabled Individuals Who
Have Exhausted Other Entitlement
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of 2025 Medicare Part A
premium for uninsured enrollees.
AGENCY:
This notice announces
Medicare’s Hospital Insurance Program
(Medicare Part A) premium for
uninsured enrollees in calendar year
(CY) 2025. This premium is paid by
enrollees aged 65 and over who are not
otherwise eligible for benefits under
Medicare Part A (hereafter known as the
‘‘uninsured aged’’) and by certain
individuals with disabilities who have
exhausted other entitlement. The
monthly Medicare Part A premium for
the 12 months beginning January 1,
2025, for these individuals will be $518.
The premium for certain other
individuals as described in this notice
will be $285.
DATES: The premium announced in this
notice is effective on January 1, 2025.
FOR FURTHER INFORMATION CONTACT:
Yaminee Thaker, (410) 786–7921.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
SUPPLEMENTARY INFORMATION:
I. Background
Section 1818 of the Social Security
Act (the Act) provides for voluntary
enrollment in Medicare Part A, subject
to payment of a monthly premium, of
certain persons aged 65 and older who
are uninsured under the Old-Age,
Survivors, and Disability Insurance
(OASDI) program or the Railroad
Retirement Act and do not otherwise
meet the requirements for entitlement to
Medicare Part A. These ‘‘uninsured
aged’’ individuals are uninsured under
the OASDI program or the Railroad
Retirement Act, because they do not
have 40 quarters of coverage under Title
II of the Act (or are/were not married to
someone who did). (Persons insured
under the OASDI program or the
Railroad Retirement Act and certain
others do not have to pay premiums for
Medicare Part A.)
Section 1818A of the Act provides for
voluntary enrollment in Medicare Part
A, subject to payment of a monthly
premium for certain individuals with
disabilities who have exhausted other
entitlement. These are individuals who
were entitled to coverage due to a
disabling impairment under section
226(b) of the Act, but who are no longer
entitled to disability benefits and
premium-free Medicare Part A coverage
because they have gone back to work
and their earnings exceed the statutorily
defined ‘‘substantial gainful activity’’
amount (section 223(d)(4) of the Act).
Section 1818A(d)(2) of the Act
specifies that the provisions relating to
premiums for the aged under section
1818(d) through section 1818(f) of the
Act will also apply to certain
individuals with disabilities as
described above.
Section 1818(d)(1) of the Act requires
us to estimate, on an average per capita
basis, the amount to be paid from the
Federal Hospital Insurance Trust Fund
for services incurred in the upcoming
calendar year (CY) (including the
associated administrative costs) on
behalf of individuals aged 65 and over
who will be entitled to benefits under
Medicare Part A. We must then
determine the monthly actuarial rate for
the following year (the per capita
amount estimated above divided by 12)
and publish the dollar amount for the
monthly premium in the succeeding CY.
If the premium is not a multiple of $1,
the premium is rounded to the nearest
multiple of $1 (or, if it is a multiple of
50 cents but not of $1, it is rounded to
the next highest $1).
Section 13508 of the Omnibus Budget
Reconciliation Act of 1993 (Pub. L. 103–
66) amended section 1818(d) of the Act
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
90015
to provide for a reduction in the
premium amount for certain voluntary
enrollees (sections 1818 and 1818A of
the Act). The reduction applies to an
individual who is eligible to buy into
the Medicare Part A program and who,
as of the last day of the previous month:
• Had at least 30 quarters of coverage
under Title II of the Act;
• Was married, and had been married
for the previous 1-year period, to a
person who had at least 30 quarters of
coverage;
• Had been married to a person for at
least 1 year at the time of the person’s
death if, at the time of death, the person
had at least 30 quarters of coverage; or
• Is divorced from a person and had
been married to the person for at least
10 years at the time of the divorce if, at
the time of the divorce, the person had
at least 30 quarters of coverage.
Section 1818(d)(4)(A) of the Act
specifies that the premium that these
individuals will pay for CY 2025 will be
equal to the premium for uninsured
aged enrollees reduced by 45 percent.
Section 1818(g) of the Act requires the
Secretary of the Department of Health
and Human Services (the Secretary), at
the request of a state, to enter into a
Medicare Part A buy-in agreement with
a state to pay Medicare Part A premiums
for Qualified Medicare Beneficiaries
(QMBs). Under the QMB program, state
Medicaid agencies must pay the
Medicare Part A premium for those not
eligible for premium-free Medicare Part
A if those individuals meet all of the
eligibility requirements for the QMB
program under the state’s Medicaid state
plan. (Entering into a Medicare Part A
buy-in agreement would permit a state
to avoid any Medicare Part A late
enrollment penalties that the individual
may owe and would allow states to
enroll persons in Medicare Part A at any
time of the year, without regard to
Medicare enrollment periods.) Other
individuals may be eligible for the
Qualified Disabled Working Individuals
program, through which state Medicaid
programs provide coverage of Medicare
Part A premiums for individuals eligible
to enroll in Medicare Part A by virtue
of section 1818A of the Act who meet
certain financial eligibility criteria.
II. Monthly Premium Amount for CY
2025
The monthly premium for the
uninsured aged and certain individuals
with disabilities who have exhausted
other entitlement for the 12 months
beginning January 1, 2025, is $518. The
monthly premium for the individuals
eligible under section 1818(d)(4)(B) of
the Act, and therefore, subject to the 45
E:\FR\FM\14NON1.SGM
14NON1
90016
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
percent reduction in the monthly
premium, is $285.
III. Monthly Premium Rate Calculation
As discussed in section I of this
notice, the monthly Medicare Part A
premium is equal to the estimated
monthly actuarial rate for CY 2025
rounded to the nearest multiple of $1
and equals one-twelfth of the average
per capita amount, which is determined
by projecting the number of Medicare
Part A enrollees aged 65 years and over,
as well as the benefits and
administrative costs that will be
incurred on their behalf.
The steps involved in projecting these
future costs to the Federal Hospital
Insurance Trust Fund are:
• Establishing the present cost of
services furnished to beneficiaries, by
type of service, to serve as a projection
base;
• Projecting increases in payment
amounts for each of the service types;
and
• Projecting increases in
administrative costs.
We base our projections for CY 2025
on—(1) current historical data; and (2)
projection assumptions derived from
current law and the President’s Fiscal
Year 2025 Budget.
For CY 2025, we estimate that
61,199,491 people aged 65 years and
over will be entitled to (enrolled in)
benefits (without premium payment)
and that they will incur about $380.149
billion in benefits and related
administrative costs. Thus, the
estimated monthly average per capita
amount is $517.64 and the monthly
premium is $518. Subsequently, the full
monthly premium reduced by 45
percent is $285.
ddrumheller on DSK120RN23PROD with NOTICES1
IV. Costs to Beneficiaries
The CY 2025 monthly premium of
$518 is approximately 2.6 percent
higher than the CY 2024 premium of
$505. We estimate that approximately
756,000 enrollees will voluntarily enroll
in Medicare Part A by paying the full
premium. We estimate that over 90
percent of these individuals will have
their Medicare Part A premium paid for
by states, since they are enrolled in the
QMB program. Furthermore, the CY
2025 reduced monthly premium of $285
is approximately 2.5 percent higher than
the CY 2024 premium of $278. We
estimate that an additional 97,000
enrollees will pay the reduced
premium. Therefore, we estimate that
the total aggregate cost to enrollees
paying these premiums in CY 2025,
compared to the amount that they paid
in CY 2024, will be about $126 million.
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
V. Waiver of Proposed Rulemaking
We ordinarily publish a notice of
proposed rulemaking in the Federal
Register and invite public comment
prior to a rule taking effect in
accordance with section 1871 of the Act
and section 553(b) of the Administrative
Procedure Act (APA). Section 1871(a)(2)
of the Act provides that no rule,
requirement, or other statement of
policy (other than a national coverage
determination) that establishes or
changes a substantive legal standard
governing the scope of benefits, the
payment for services, or the eligibility of
individuals, entities, or organizations to
furnish or receive services or benefits
under Medicare shall take effect unless
it is promulgated through notice and
comment rulemaking. Unless there is a
statutory exception, section 1871(b)(1)
of the Act generally requires the
Secretary to provide for notice of a
proposed rule in the Federal Register
and provide a period of not less than 60
days for public comment before
establishing or changing a substantive
legal standard regarding the matters
enumerated by the statute. Similarly,
under 5 U.S.C. 553(b) of the APA, the
agency is required to publish a notice of
proposed rulemaking in the Federal
Register before a substantive rule takes
effect. Section 553(d) of the APA and
section 1871(e)(1)(B)(i) of the Act
usually require a 30-day delay in
effective date after issuance or
publication of a rule, subject to
exceptions. Sections 553(b)(B) and
553(d)(3) of the APA provide for
exceptions from the advance notice and
comment requirement and the delay in
effective date requirements. Sections
1871(b)(2)(C) and 1871(e)(1)(B)(ii) of the
Act also provide exceptions from the
notice and 60-day comment period and
the 30-day delay in effective date.
Section 553(b)(B) of the APA and
section 1871(b)(2)(C) of the Act
expressly authorize an agency to
dispense with notice and comment
rulemaking for good cause if the agency
makes a finding that notice and
comment procedures are impracticable,
unnecessary, or contrary to the public
interest.
The annual Medicare Part A premium
announcement set forth in this notice
does not establish or change a
substantive legal standard regarding the
matters enumerated by the statute or
constitute a substantive rule which
would be subject to the notice
requirements in section 553(b) of the
APA. However, to the extent that an
opportunity for public notice and
comment could be construed as
required for this notice, we find good
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
cause to waive this requirement. Section
1818(d) of the Act requires the Secretary
during September of each year to
determine and publish the amount to be
paid, on an average per capita basis,
from the Federal Hospital Insurance
Trust Fund for services incurred in the
impending CY (including the associated
administrative costs) on behalf of
individuals aged 65 and over who will
be entitled to benefits under Medicare
Part A. Further, the statute requires that
the agency determine the applicable
premium amount for each CY in
accordance with the statutory formula,
and we are simply notifying the public
of the changes to the Medicare Part A
premiums for CY 2025. We have
calculated the Medicare Part A
premiums as directed by the statute; the
statute establishes both when the
premium amounts must be published
and the information that the Secretary
must factor into the premium amounts,
so we do not have any discretion in that
regard. We find notice and comment
procedures to be unnecessary for this
notice and we find good cause to waive
such procedures under section 553(b)(B)
of the APA and section 1871(b)(2)(C) of
the Act, if such procedures may be
construed to be required at all. Through
this notice, we are simply notifying the
public of the updates to the Medicare
Part A premiums, in accordance with
the statute, for CY 2025. As such, we
also note that even if notice and
comment procedures were required for
this notice, for the reasons stated above,
we would find good cause to waive the
delay in effective date of the notice, as
additional delay would be contrary to
the public interest under section
1871(e)(1)(B)(ii) of the Act. Publication
of this notice is consistent with section
1818(d) of the Act, and we believe that
any potential delay in the effective date
of the notice, if such delay were
required at all, could cause unnecessary
confusion both for the agency and
Medicare beneficiaries.
VI. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
VII. Regulatory Impact Analysis
Although this notice does not
constitute a significant regulatory action
(defined below), we nevertheless
prepared this Regulatory Impact
E:\FR\FM\14NON1.SGM
14NON1
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
Analysis (RIA) section in the interest of
ensuring that the impacts of this notice
are fully understood.
ddrumheller on DSK120RN23PROD with NOTICES1
A. Statement of Need
This notice announces the CY 2025
Medicare Part A premiums for the
uninsured aged and for certain disabled
individuals who have exhausted other
entitlement, as required by sections
1818 and 1818A of the Act. It also
responds to section 1818(d) of the Act,
which requires the Secretary to provide
for publication of these amounts in the
Federal Register during the September
that precedes the start of each CY. As
this statutory provision prescribes a
detailed methodology for calculating
these amounts, we do not have the
discretion to adopt an alternative
approach on these issues.
B. Overall Impact
We have examined the impacts of this
rule as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993), Executive
Order 13563 on Improving Regulation
and Regulatory Review (January 18,
2011), Executive Order 14094 titled
‘‘Modernizing Regulatory Review’’
(April 6, 2023), the Regulatory
Flexibility Act (RFA) (September 19,
1980, Pub. L. 96–354), section 1102(b) of
the Social Security Act, section 202 of
the Unfunded Mandates Reform Act of
1995 (March 22, 1995; Pub. L. 104–4),
Executive Order 13132 on Federalism
(August 4, 1999), and the Congressional
Review Act (5 U.S.C. 804(2)).
Executive Orders 12866 and 13563
direct agencies to assess all costs and
benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). The Executive Order 14094
titled ‘‘Modernizing Regulatory Review’’
amends section 3(f)(1) of Executive
Order 12866 (Regulatory Planning and
Review). The amended section 3(f) of
Executive Order 12866 defines a
‘‘significant regulatory action’’ as an
action that is likely to result in a rule
that may: (1) have an annual effect on
the economy of $200 million or more,
(adjusted every 3 years by the
Administrator of OMB’s Office of
Information and Regulatory Affairs
(OIRA) for changes in gross domestic
product); or adversely affect in a
material way the economy, a sector of
the economy, productivity, competition,
jobs, the environment, public health or
safety, or State, local, territorial, or tribal
governments or communities; (2) create
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
a serious inconsistency or otherwise
interfere with an action taken or
planned by another agency; (3)
materially alter the budgetary impacts of
entitlement grants, user fees, or loan
programs or the rights and obligations of
recipients thereof; or (4) raise legal or
policy issues for which centralized
review would meaningfully further the
President’s priorities or the principles
set forth in this Executive order, as
specifically authorized in a timely
manner by OIRA in each case.
A regulatory impact analysis (RIA)
must be prepared for rules with
significant regulatory action(s) as per
section 3(f)(1) of Executive Order 12866
($200 million or more in any one year).
Based on our estimates, OIRA has
determined that this notice is not
significant per section 3(f)(1) of E.O.
12866 as measured by the $200 million
or more impact in any one year.
In accordance with the Congressional
Review Act, OIRA has determined that
this notice meets the criteria set forth in
5 U.S.C. 804(2). Accordingly, we have
prepared an RIA that to the best of our
ability presents the costs and benefits of
this notice.
As stated in section IV. of this notice,
we estimate that the overall effect of the
changes in the Medicare Part A
premium will be a cost to voluntary
enrollees (sections 1818 and 1818A of
the Act) of about $126 million.
C. Accounting Statement and Table
As required by OMB Circular A–4
(available at https://
www.whitehouse.gov/wp-content/
uploads/legacy_drupal_files/omb/
circulars/A4/a-4.pdf), in the table 1, we
have prepared an accounting statement
showing the total aggregate cost to
enrollees paying premiums in CY 2025,
compared to the amount that they paid
in CY 2024. This amount is
approximately $126 million. As stated
in section IV. of this notice, the CY 2025
premium of $518 is approximately 2.6
percent higher than the CY 2024
premium of $505. We estimate that
approximately 756,000 enrollees will
voluntarily enroll in Medicare Part A by
paying the full premium. We estimate
that over 90 percent of these individuals
will have their Medicare Part A
premium paid for by states, since they
are enrolled in the QMB program.
Furthermore, the CY 2025 reduced
premium of $285 is approximately 2.5
percent higher than the CY 2024
premium of $278.
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
90017
TABLE 1—ESTIMATED TRANSFERS FOR
CY 2025 MEDICARE PART A PREMIUMS
Period
covered
Category
Transfers
Annualized
Monetized
Transfers.
From Whom to
Whom.
$126 million .....
2025
Beneficiaries to
Federal Government.
................
D. Regulatory Flexibility Act
The RFA requires agencies to analyze
options for regulatory relief of small
entities, if a rule has a significant impact
on a substantial number of small
entities. For purposes of the RFA, small
entities include small businesses,
nonprofit organizations, and small
governmental jurisdictions. Most
hospitals and most other providers and
suppliers are small entities, either by
being nonprofit organizations or by
meeting the Small Business
Administration’s (SBA) definition of a
small business (having revenues of less
than $9.0 million to $47 million in any
1 year). Individuals and states are not
included in the definition of a small
entity. This annual notice announces
the Medicare Part A premiums for CY
2025 and will have an impact on certain
Medicare beneficiaries, but not on small
entities as defined by the SBA. As a
result, we are not preparing an analysis
for the RFA because the Secretary has
certified that this notice will not have a
significant economic impact on a
substantial number of small entities.
In addition, section 1102(b) of the Act
requires us to prepare an RIA if a rule
may have a significant impact on the
operations of a substantial number of
small rural hospitals. This analysis must
conform to the provisions of section 604
of the RFA. For purposes of section
1102(b) of the Act, we define a small
rural hospital as a hospital that is
located outside of a metropolitan
statistical area and has fewer than 100
beds. This annual notice announces the
Medicare Part A premiums for CY 2025
and will have an impact on certain
Medicare beneficiaries. As a result, we
are not preparing an analysis for section
1102(b) of the Act, because the Secretary
has certified that this notice will not
have a significant impact on the
operations of a substantial number of
small rural hospitals.
E. Unfunded Mandates Reform Act
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
E:\FR\FM\14NON1.SGM
14NON1
90018
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
rule whose mandates require spending
in any 1 year of $100 million in 1995
dollars, updated annually for inflation.
In 2024, that threshold is approximately
$183 million. This notice would not
impose a mandate that will result in the
expenditure by state, local, and Tribal
Governments, in the aggregate, or by the
private sector, of more than $183
million in any 1 year.
F. Federalism
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on state and local
governments, preempts state law, or
otherwise has federalism implications.
This notice will not have a substantial
direct effect on state or local
governments, preempt state law, or
otherwise have federalism implications.
G. Congressional Review
This notice is subject to the
Congressional Review Act and has been
transmitted to the Congress and the
Government Accountability Office’s
Comptroller General for review.
Chiquita Brooks-LaSure,
Administrator of the Centers for
Medicare & Medicaid Services,
approved this document on October 31,
2024.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
[FR Doc. 2024–26473 Filed 11–8–24; 4:15 pm]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2024–N–4815]
Patient-Focused Drug Development:
Workshop To Discuss Methodologic
and Other Challenges Related to
Patient Experience Data; Public
Workshop; Request for Comments
AGENCY:
Food and Drug Administration,
HHS
Notice of public workshop;
request for comments.
ddrumheller on DSK120RN23PROD with NOTICES1
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following virtual
public workshop entitled ‘‘PatientFocused Drug Development: Workshop
to Discuss Methodologic and Other
Challenges Related to Patient
Experience Data.’’ The purpose of the
public workshop is to discuss
SUMMARY:
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
methodological challenges related to
patient experience data, and other areas
of greatest interest or concern to public
stakeholders.
DATES: The public workshop will be
held virtually on December 13, 2024,
from 10 a.m. to 5 p.m. Eastern Time.
Either electronic or written comments
on this public meeting must be
submitted by February 11, 2025. See the
SUPPLEMENTARY INFORMATION section for
registration date and information.
ADDRESSES: The public workshop will
be held virtually using the Zoom
platform.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of February 11, 2025.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are received on or before that
date.
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2024–N–4815 for ‘‘Patient-Focused Drug
Development: Workshop to Discuss
Methodologic and Other Challenges
Related to Patient Experience Data.’’
Received comments, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
E:\FR\FM\14NON1.SGM
14NON1
Agencies
[Federal Register Volume 89, Number 220 (Thursday, November 14, 2024)]
[Notices]
[Pages 90015-90018]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26473]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-8087-N]
RIN 0938-AV37
Medicare Program; CY 2025 Part A Premiums for the Uninsured Aged
and for Certain Disabled Individuals Who Have Exhausted Other
Entitlement
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of 2025 Medicare Part A premium for uninsured enrollees.
-----------------------------------------------------------------------
SUMMARY: This notice announces Medicare's Hospital Insurance Program
(Medicare Part A) premium for uninsured enrollees in calendar year (CY)
2025. This premium is paid by enrollees aged 65 and over who are not
otherwise eligible for benefits under Medicare Part A (hereafter known
as the ``uninsured aged'') and by certain individuals with disabilities
who have exhausted other entitlement. The monthly Medicare Part A
premium for the 12 months beginning January 1, 2025, for these
individuals will be $518. The premium for certain other individuals as
described in this notice will be $285.
DATES: The premium announced in this notice is effective on January 1,
2025.
FOR FURTHER INFORMATION CONTACT: Yaminee Thaker, (410) 786-7921.
SUPPLEMENTARY INFORMATION:
I. Background
Section 1818 of the Social Security Act (the Act) provides for
voluntary enrollment in Medicare Part A, subject to payment of a
monthly premium, of certain persons aged 65 and older who are uninsured
under the Old-Age, Survivors, and Disability Insurance (OASDI) program
or the Railroad Retirement Act and do not otherwise meet the
requirements for entitlement to Medicare Part A. These ``uninsured
aged'' individuals are uninsured under the OASDI program or the
Railroad Retirement Act, because they do not have 40 quarters of
coverage under Title II of the Act (or are/were not married to someone
who did). (Persons insured under the OASDI program or the Railroad
Retirement Act and certain others do not have to pay premiums for
Medicare Part A.)
Section 1818A of the Act provides for voluntary enrollment in
Medicare Part A, subject to payment of a monthly premium for certain
individuals with disabilities who have exhausted other entitlement.
These are individuals who were entitled to coverage due to a disabling
impairment under section 226(b) of the Act, but who are no longer
entitled to disability benefits and premium-free Medicare Part A
coverage because they have gone back to work and their earnings exceed
the statutorily defined ``substantial gainful activity'' amount
(section 223(d)(4) of the Act).
Section 1818A(d)(2) of the Act specifies that the provisions
relating to premiums for the aged under section 1818(d) through section
1818(f) of the Act will also apply to certain individuals with
disabilities as described above.
Section 1818(d)(1) of the Act requires us to estimate, on an
average per capita basis, the amount to be paid from the Federal
Hospital Insurance Trust Fund for services incurred in the upcoming
calendar year (CY) (including the associated administrative costs) on
behalf of individuals aged 65 and over who will be entitled to benefits
under Medicare Part A. We must then determine the monthly actuarial
rate for the following year (the per capita amount estimated above
divided by 12) and publish the dollar amount for the monthly premium in
the succeeding CY. If the premium is not a multiple of $1, the premium
is rounded to the nearest multiple of $1 (or, if it is a multiple of 50
cents but not of $1, it is rounded to the next highest $1).
Section 13508 of the Omnibus Budget Reconciliation Act of 1993
(Pub. L. 103-66) amended section 1818(d) of the Act to provide for a
reduction in the premium amount for certain voluntary enrollees
(sections 1818 and 1818A of the Act). The reduction applies to an
individual who is eligible to buy into the Medicare Part A program and
who, as of the last day of the previous month:
Had at least 30 quarters of coverage under Title II of the
Act;
Was married, and had been married for the previous 1-year
period, to a person who had at least 30 quarters of coverage;
Had been married to a person for at least 1 year at the
time of the person's death if, at the time of death, the person had at
least 30 quarters of coverage; or
Is divorced from a person and had been married to the
person for at least 10 years at the time of the divorce if, at the time
of the divorce, the person had at least 30 quarters of coverage.
Section 1818(d)(4)(A) of the Act specifies that the premium that
these individuals will pay for CY 2025 will be equal to the premium for
uninsured aged enrollees reduced by 45 percent.
Section 1818(g) of the Act requires the Secretary of the Department
of Health and Human Services (the Secretary), at the request of a
state, to enter into a Medicare Part A buy-in agreement with a state to
pay Medicare Part A premiums for Qualified Medicare Beneficiaries
(QMBs). Under the QMB program, state Medicaid agencies must pay the
Medicare Part A premium for those not eligible for premium-free
Medicare Part A if those individuals meet all of the eligibility
requirements for the QMB program under the state's Medicaid state plan.
(Entering into a Medicare Part A buy-in agreement would permit a state
to avoid any Medicare Part A late enrollment penalties that the
individual may owe and would allow states to enroll persons in Medicare
Part A at any time of the year, without regard to Medicare enrollment
periods.) Other individuals may be eligible for the Qualified Disabled
Working Individuals program, through which state Medicaid programs
provide coverage of Medicare Part A premiums for individuals eligible
to enroll in Medicare Part A by virtue of section 1818A of the Act who
meet certain financial eligibility criteria.
II. Monthly Premium Amount for CY 2025
The monthly premium for the uninsured aged and certain individuals
with disabilities who have exhausted other entitlement for the 12
months beginning January 1, 2025, is $518. The monthly premium for the
individuals eligible under section 1818(d)(4)(B) of the Act, and
therefore, subject to the 45
[[Page 90016]]
percent reduction in the monthly premium, is $285.
III. Monthly Premium Rate Calculation
As discussed in section I of this notice, the monthly Medicare Part
A premium is equal to the estimated monthly actuarial rate for CY 2025
rounded to the nearest multiple of $1 and equals one-twelfth of the
average per capita amount, which is determined by projecting the number
of Medicare Part A enrollees aged 65 years and over, as well as the
benefits and administrative costs that will be incurred on their
behalf.
The steps involved in projecting these future costs to the Federal
Hospital Insurance Trust Fund are:
Establishing the present cost of services furnished to
beneficiaries, by type of service, to serve as a projection base;
Projecting increases in payment amounts for each of the
service types; and
Projecting increases in administrative costs.
We base our projections for CY 2025 on--(1) current historical
data; and (2) projection assumptions derived from current law and the
President's Fiscal Year 2025 Budget.
For CY 2025, we estimate that 61,199,491 people aged 65 years and
over will be entitled to (enrolled in) benefits (without premium
payment) and that they will incur about $380.149 billion in benefits
and related administrative costs. Thus, the estimated monthly average
per capita amount is $517.64 and the monthly premium is $518.
Subsequently, the full monthly premium reduced by 45 percent is $285.
IV. Costs to Beneficiaries
The CY 2025 monthly premium of $518 is approximately 2.6 percent
higher than the CY 2024 premium of $505. We estimate that approximately
756,000 enrollees will voluntarily enroll in Medicare Part A by paying
the full premium. We estimate that over 90 percent of these individuals
will have their Medicare Part A premium paid for by states, since they
are enrolled in the QMB program. Furthermore, the CY 2025 reduced
monthly premium of $285 is approximately 2.5 percent higher than the CY
2024 premium of $278. We estimate that an additional 97,000 enrollees
will pay the reduced premium. Therefore, we estimate that the total
aggregate cost to enrollees paying these premiums in CY 2025, compared
to the amount that they paid in CY 2024, will be about $126 million.
V. Waiver of Proposed Rulemaking
We ordinarily publish a notice of proposed rulemaking in the
Federal Register and invite public comment prior to a rule taking
effect in accordance with section 1871 of the Act and section 553(b) of
the Administrative Procedure Act (APA). Section 1871(a)(2) of the Act
provides that no rule, requirement, or other statement of policy (other
than a national coverage determination) that establishes or changes a
substantive legal standard governing the scope of benefits, the payment
for services, or the eligibility of individuals, entities, or
organizations to furnish or receive services or benefits under Medicare
shall take effect unless it is promulgated through notice and comment
rulemaking. Unless there is a statutory exception, section 1871(b)(1)
of the Act generally requires the Secretary to provide for notice of a
proposed rule in the Federal Register and provide a period of not less
than 60 days for public comment before establishing or changing a
substantive legal standard regarding the matters enumerated by the
statute. Similarly, under 5 U.S.C. 553(b) of the APA, the agency is
required to publish a notice of proposed rulemaking in the Federal
Register before a substantive rule takes effect. Section 553(d) of the
APA and section 1871(e)(1)(B)(i) of the Act usually require a 30-day
delay in effective date after issuance or publication of a rule,
subject to exceptions. Sections 553(b)(B) and 553(d)(3) of the APA
provide for exceptions from the advance notice and comment requirement
and the delay in effective date requirements. Sections 1871(b)(2)(C)
and 1871(e)(1)(B)(ii) of the Act also provide exceptions from the
notice and 60-day comment period and the 30-day delay in effective
date. Section 553(b)(B) of the APA and section 1871(b)(2)(C) of the Act
expressly authorize an agency to dispense with notice and comment
rulemaking for good cause if the agency makes a finding that notice and
comment procedures are impracticable, unnecessary, or contrary to the
public interest.
The annual Medicare Part A premium announcement set forth in this
notice does not establish or change a substantive legal standard
regarding the matters enumerated by the statute or constitute a
substantive rule which would be subject to the notice requirements in
section 553(b) of the APA. However, to the extent that an opportunity
for public notice and comment could be construed as required for this
notice, we find good cause to waive this requirement. Section 1818(d)
of the Act requires the Secretary during September of each year to
determine and publish the amount to be paid, on an average per capita
basis, from the Federal Hospital Insurance Trust Fund for services
incurred in the impending CY (including the associated administrative
costs) on behalf of individuals aged 65 and over who will be entitled
to benefits under Medicare Part A. Further, the statute requires that
the agency determine the applicable premium amount for each CY in
accordance with the statutory formula, and we are simply notifying the
public of the changes to the Medicare Part A premiums for CY 2025. We
have calculated the Medicare Part A premiums as directed by the
statute; the statute establishes both when the premium amounts must be
published and the information that the Secretary must factor into the
premium amounts, so we do not have any discretion in that regard. We
find notice and comment procedures to be unnecessary for this notice
and we find good cause to waive such procedures under section 553(b)(B)
of the APA and section 1871(b)(2)(C) of the Act, if such procedures may
be construed to be required at all. Through this notice, we are simply
notifying the public of the updates to the Medicare Part A premiums, in
accordance with the statute, for CY 2025. As such, we also note that
even if notice and comment procedures were required for this notice,
for the reasons stated above, we would find good cause to waive the
delay in effective date of the notice, as additional delay would be
contrary to the public interest under section 1871(e)(1)(B)(ii) of the
Act. Publication of this notice is consistent with section 1818(d) of
the Act, and we believe that any potential delay in the effective date
of the notice, if such delay were required at all, could cause
unnecessary confusion both for the agency and Medicare beneficiaries.
VI. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
VII. Regulatory Impact Analysis
Although this notice does not constitute a significant regulatory
action (defined below), we nevertheless prepared this Regulatory Impact
[[Page 90017]]
Analysis (RIA) section in the interest of ensuring that the impacts of
this notice are fully understood.
A. Statement of Need
This notice announces the CY 2025 Medicare Part A premiums for the
uninsured aged and for certain disabled individuals who have exhausted
other entitlement, as required by sections 1818 and 1818A of the Act.
It also responds to section 1818(d) of the Act, which requires the
Secretary to provide for publication of these amounts in the Federal
Register during the September that precedes the start of each CY. As
this statutory provision prescribes a detailed methodology for
calculating these amounts, we do not have the discretion to adopt an
alternative approach on these issues.
B. Overall Impact
We have examined the impacts of this rule as required by Executive
Order 12866 on Regulatory Planning and Review (September 30, 1993),
Executive Order 13563 on Improving Regulation and Regulatory Review
(January 18, 2011), Executive Order 14094 titled ``Modernizing
Regulatory Review'' (April 6, 2023), the Regulatory Flexibility Act
(RFA) (September 19, 1980, Pub. L. 96-354), section 1102(b) of the
Social Security Act, section 202 of the Unfunded Mandates Reform Act of
1995 (March 22, 1995; Pub. L. 104-4), Executive Order 13132 on
Federalism (August 4, 1999), and the Congressional Review Act (5 U.S.C.
804(2)).
Executive Orders 12866 and 13563 direct agencies to assess all
costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory approaches that maximize
net benefits (including potential economic, environmental, public
health and safety effects, distributive impacts, and equity). The
Executive Order 14094 titled ``Modernizing Regulatory Review'' amends
section 3(f)(1) of Executive Order 12866 (Regulatory Planning and
Review). The amended section 3(f) of Executive Order 12866 defines a
``significant regulatory action'' as an action that is likely to result
in a rule that may: (1) have an annual effect on the economy of $200
million or more, (adjusted every 3 years by the Administrator of OMB's
Office of Information and Regulatory Affairs (OIRA) for changes in
gross domestic product); or adversely affect in a material way the
economy, a sector of the economy, productivity, competition, jobs, the
environment, public health or safety, or State, local, territorial, or
tribal governments or communities; (2) create a serious inconsistency
or otherwise interfere with an action taken or planned by another
agency; (3) materially alter the budgetary impacts of entitlement
grants, user fees, or loan programs or the rights and obligations of
recipients thereof; or (4) raise legal or policy issues for which
centralized review would meaningfully further the President's
priorities or the principles set forth in this Executive order, as
specifically authorized in a timely manner by OIRA in each case.
A regulatory impact analysis (RIA) must be prepared for rules with
significant regulatory action(s) as per section 3(f)(1) of Executive
Order 12866 ($200 million or more in any one year). Based on our
estimates, OIRA has determined that this notice is not significant per
section 3(f)(1) of E.O. 12866 as measured by the $200 million or more
impact in any one year.
In accordance with the Congressional Review Act, OIRA has
determined that this notice meets the criteria set forth in 5 U.S.C.
804(2). Accordingly, we have prepared an RIA that to the best of our
ability presents the costs and benefits of this notice.
As stated in section IV. of this notice, we estimate that the
overall effect of the changes in the Medicare Part A premium will be a
cost to voluntary enrollees (sections 1818 and 1818A of the Act) of
about $126 million.
C. Accounting Statement and Table
As required by OMB Circular A-4 (available at https://www.whitehouse.gov/wp-content/uploads/legacy_drupal_files/omb/circulars/A4/a-4.pdf), in the table 1, we have prepared an accounting
statement showing the total aggregate cost to enrollees paying premiums
in CY 2025, compared to the amount that they paid in CY 2024. This
amount is approximately $126 million. As stated in section IV. of this
notice, the CY 2025 premium of $518 is approximately 2.6 percent higher
than the CY 2024 premium of $505. We estimate that approximately
756,000 enrollees will voluntarily enroll in Medicare Part A by paying
the full premium. We estimate that over 90 percent of these individuals
will have their Medicare Part A premium paid for by states, since they
are enrolled in the QMB program. Furthermore, the CY 2025 reduced
premium of $285 is approximately 2.5 percent higher than the CY 2024
premium of $278.
Table 1--Estimated Transfers for CY 2025 Medicare Part A Premiums
------------------------------------------------------------------------
Period
Category Transfers covered
------------------------------------------------------------------------
Annualized Monetized Transfers...... $126 million........... 2025
From Whom to Whom................... Beneficiaries to .........
Federal Government.
------------------------------------------------------------------------
D. Regulatory Flexibility Act
The RFA requires agencies to analyze options for regulatory relief
of small entities, if a rule has a significant impact on a substantial
number of small entities. For purposes of the RFA, small entities
include small businesses, nonprofit organizations, and small
governmental jurisdictions. Most hospitals and most other providers and
suppliers are small entities, either by being nonprofit organizations
or by meeting the Small Business Administration's (SBA) definition of a
small business (having revenues of less than $9.0 million to $47
million in any 1 year). Individuals and states are not included in the
definition of a small entity. This annual notice announces the Medicare
Part A premiums for CY 2025 and will have an impact on certain Medicare
beneficiaries, but not on small entities as defined by the SBA. As a
result, we are not preparing an analysis for the RFA because the
Secretary has certified that this notice will not have a significant
economic impact on a substantial number of small entities.
In addition, section 1102(b) of the Act requires us to prepare an
RIA if a rule may have a significant impact on the operations of a
substantial number of small rural hospitals. This analysis must conform
to the provisions of section 604 of the RFA. For purposes of section
1102(b) of the Act, we define a small rural hospital as a hospital that
is located outside of a metropolitan statistical area and has fewer
than 100 beds. This annual notice announces the Medicare Part A
premiums for CY 2025 and will have an impact on certain Medicare
beneficiaries. As a result, we are not preparing an analysis for
section 1102(b) of the Act, because the Secretary has certified that
this notice will not have a significant impact on the operations of a
substantial number of small rural hospitals.
E. Unfunded Mandates Reform Act
Section 202 of the Unfunded Mandates Reform Act of 1995 also
requires that agencies assess anticipated costs and benefits before
issuing any
[[Page 90018]]
rule whose mandates require spending in any 1 year of $100 million in
1995 dollars, updated annually for inflation. In 2024, that threshold
is approximately $183 million. This notice would not impose a mandate
that will result in the expenditure by state, local, and Tribal
Governments, in the aggregate, or by the private sector, of more than
$183 million in any 1 year.
F. Federalism
Executive Order 13132 establishes certain requirements that an
agency must meet when it promulgates a proposed rule (and subsequent
final rule) that imposes substantial direct requirement costs on state
and local governments, preempts state law, or otherwise has federalism
implications. This notice will not have a substantial direct effect on
state or local governments, preempt state law, or otherwise have
federalism implications.
G. Congressional Review
This notice is subject to the Congressional Review Act and has been
transmitted to the Congress and the Government Accountability Office's
Comptroller General for review.
Chiquita Brooks-LaSure, Administrator of the Centers for Medicare &
Medicaid Services, approved this document on October 31, 2024.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2024-26473 Filed 11-8-24; 4:15 pm]
BILLING CODE 4120-01-P